KUALA LUMPUR: The Health Ministry has enrolled its first patient for the World Health Organisation (WHO)-led Solidarity Trial that will attempt to find the best drug to treat Covid-19 patients, says the ministry’s Clinical Research Centre director Dr Goh Pik Pin.
Dr Goh, who is the coordinator for the trial in Malaysia, said that the patient was enrolled on Tuesday (April 21).
“With this, Malaysia will contribute to the evidence the world needs in identifying efficacious treatment regiment for Covid-19 patients,” she said in a tweet on late Tuesday.
The Solidarity Trial, launched by WHO, is an international effort to test several drugs on Covid-19 patients.
On Sunday (April 19), Health director-general Datuk Dr Noor Hisham Abdullah said that nine government hospitals would be participating in the Solidarity Trial using different combinations of remdesivir, lopinavir/ritonavir, interferon beta, chloroquine and hydroxychloroquine.
The use of the drugs would be evaluated by regulatory bodies the National Pharmaceutical Regulatory Agency and Medical Research and Ethics Committee.
Find out more at: https://www.thestar.com.my/news/nation/2020/04/23/malaysia-enrols-first-patient-for-drug-trial